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www.jacc-interventions.org to view.Noninvasive Discrimination of Coronary Chronic Total Occlusion and Subtotal Occlusion
by Coronary Computed Tomography Angiography1143Jin-Ho Choi, Eun-Kyoung Kim, Sung Mok Kim, Hyungyoon Kim, Young Bin Song,
Joo-Yong Hahn, Seung Hyuk Choi, Hyeon-Cheol Gwon, Sang-Hoon Lee,
Yeon Hyeon Choe, Jae K. OhThe authors investigated whether noninvasive coronary computed tomography angiography (CTA)
can discriminate coronary chronic total occlusion (CTO) from subtotal occlusion (STO). The
morphological ﬁndings including the lesion length, side branch, cross-sectional calciﬁcation,
collateral vessels, and functional ﬁndings by transluminal attenuation gradient were investigated
from 553 totally occluded vessels. CTA could discriminate CTO from STO (c-statistics ¼ 0.88). CTA
also predicted the unsuccessful result of 243 attempted percutaneous coronary interventions
(c-statistics ¼ 0.70). Hence, comprehensive assessment of anatomical and physiological ﬁndings of
coronary CTA could discern CTO from STO.n EDITORIAL COMMENT
Discrimination of Coronary Subtotal Occlusion and Chronic Total Occlusion by
Computed Tomographic Angiography1154William J. Nicholson, Gerald S. Werner
Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus-
and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice:
The COMPARE Trial (A Trial of Everolimus-Eluting Stents and Paclitaxel Stents
for Coronary Revascularization in Daily Practice)1157Pieter C. Smits, Georgios J. Vlachojannis, Eugene Patrick McFadden, Kees-Jan Royaards,
Jochem Wassing, Kaiyum Sheik Joesoef, Carlos van Mieghem, Martin van de EntUse of everolimus-eluting stents (EES) compared with paclitaxel-eluting stents has been associated
with improved clinical outcomes. This study shows that these beneﬁts are sustained at 5 years in
an all-comers PCI population, resulting in fewer myocardial infarctions, target vessel
revascularizations, and stent thrombosis. The hazard curves for these endpoints diverge over the
ﬁrst 3 years and, subsequently, progress in parallel. This study reports on 5-year clinical outcomes
of EES in an all-comers percutaneous coronary intervention population, conﬁrming its durable
efﬁcacy and safety proﬁle.CONTINUED ON PAGE A-19
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AUGUST 17, 2015 VOLUME 8, NUMBER 9A Combined Optical Coherence Tomography and Intravascular Ultrasound Study on
Plaque Rupture, Plaque Erosion, and Calciﬁed Nodule in Patients With ST-Segment
Elevation Myocardial Infarction: Incidence, Morphologic Characteristics, and Outcomes
After Percutaneous Coronary Intervention1166Takumi Higuma, Tsunenari Soeda, Naoki Abe, Masahiro Yamada, Hiroaki Yokoyama,
Shuji Shibutani, Rocco Vergallo, Yoshiyasu Minami, Daniel S. Ong, Hang Lee,
Ken Okumura, Ik-Kyung JangThe incidence and morphologic features of plaque rupture (PR), plaque erosion (PE), and calciﬁed
nodule (CN) in patients with ST-segment elevation myocardial infarction (STEMI) and their
outcome after percutaneous coronary intervention are unknown. The authors investigated 112
STEMI patients who were imaged by optical coherence tomography and intravascular ultrasound.
The incidence of PR, PE, and CN in STEMI culprit lesion was 64.3%, 26.8%, and 8.0% by optical
coherence tomography. PR frequently had features of plaque vulnerability. PE was characterized
by eccentric ﬁbrous plaque. CN was characterized by superﬁcial large calciﬁcation and negative
remodeling. PE is associated with less no-reﬂow phenomenon than PR.n EDITORIAL COMMENT
Illuminating Culprit Plaque Histology by Optical Coherence Tomography:
Shedding New Light on Old Insights1177Aloke V. Finn
Incidence and Clinical Impact of Stent Fracture After PROMUS Element Platinum
Chromium Everolimus-Eluting Stent Implantation1180Shoichi Kuramitsu, Takashi Hiromasa, Soichiro Enomoto, Tomohiro Shinozaki,
Masashi Iwabuchi, Toru Mazaki, Takenori Domei, Kyohei Yamaji, Yoshimitsu Soga,
Makoto Hyodo, Shinichi Shirai, Kenji AndoThe authors assessed the incidence and clinical impact of stent fracture (SF) after platinum-chromium
everolimus-eluting stent (PtCr-EES) implantation. A total of 700 patients with 898 lesions undergoing
PtCr-EES implantation were analyzed. SF was observed in 16 of 898 lesions (1.7%). Lesions with in-
stent restenosis or hinge motion, and total stent length were predictors of SF. Cumulative incidence of
clinically driven target lesion revascularization within 9 months after the index procedure was
numerically higher in the SF group than that in the non-SF group (18.7% vs. 2.3%), whereas deﬁnite
stent thrombosis did not occur in the SF group. PtCr-EES may reduce the incidence of SF to the utmost
limit of a metallic drug-eluting stent.
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AUGUST 17, 2015 VOLUME 8, NUMBER 9RADIATION SAFETY Effect of Vascular Access Site Choice on Radiation Exposure During Coronary Angiography:
The REVERE Trial (Randomized Evaluation of Vascular Entry Site and Radiation Exposure)1189Samir B. Pancholy, Pankaj Joshi, Sanjay Shah, Sunil V. Rao, Olivier F. Bertrand,
Tejas M. PatelThe data comparing radiation exposure and access sites are controversial. This study randomized 1,493
patients undergoing cardiac catheterization to femoral, left radial, or right radial access to determine the
effect of assigned access site on air kerma, dose-area product, and ﬂuoroscopy time. No signiﬁcant
differences in air kerma, dose-area product, or ﬂuoroscopy time were observed among the 3 access sites.
Operator radiation exposure was higher with LRA procedures than with RRA or FA procedures.
SEE ADDITIONAL CONTENT ONLINEInvasive Cardiologists Are Exposed to Greater Left Sided Cranial Radiation:
The BRAIN Study (Brain Radiation Exposure and Attenuation During Invasive
Cardiology Procedures)1197Ryan R. Reeves, Lawrence Ang, John Bahadorani, Jesse Naghi, Arturo Dominguez,
Vachaspathi Palakodeti, Sotirios Tsimikas, Mitul P. Patel, Ehtisham MahmudThis study was undertaken to determine radiation exposure across the cranium of cardiologists and the
protective ability of a nonlead XPF (barium sulfate/bismuth oxide) layered cap (BLOXR, Salt Lake City,
Utah) during ﬂuoroscopically guided, invasive cardiovascular procedures. Eleven physicians performed
cardiovascular procedures (n ¼ 66.2  27 cases/operator); exposure at the outside left was 16 times
higher than that at the inside left (p < 0.001), and exposure at the outside center was 11 times higher
than that at the inside center (p < 0.001), whereas no difference was observed on the right side of the
cranium. The XPF cap attenuated radiation exposure to a level similar to that of an ambient control.STRUCTURAL Health Status After Transcatheter or Surgical Aortic Valve Replacement in
Patients With Severe Aortic Stenosis at Increased Surgical Risk:
Results From the CoreValve US Pivotal Trial1207Suzanne V. Arnold, Matthew R. Reynolds, Kaijun Wang, Elizabeth A. Magnuson,
Suzanne J. Baron, Khaja M. Chinnakondepalli, Michael J. Reardon, Peter N. Tadros,
George L. Zorn, Brij Maini, Mubashir A. Mumtaz, John M. Brown, Robert M. Kipperman,
David H. Adams, Jeffrey J. Popma, David J. Cohen, for the CoreValve US Pivotal
Trial InvestigatorsThe authors compared the health status outcomes of 795 patients treated with self-expanding
transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (AVR) as part
of the CoreValve US Pivotal Trial. Disease-speciﬁc and generic health status improved substantially
over time for both treatment groups. Among patients eligible for iliofemoral access, there was a
clinically relevant early beneﬁt with TAVR, with greater improvements in heart failure symptoms,
physical function, and quality of life. Among the noniliofemoral cohort, health status measures
were similar for TAVR and AVR. There were no consistent differences in health status between
groups at later time points.
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AUGUST 17, 2015 VOLUME 8, NUMBER 9Inverse Relationship Between Membranous Septal Length and the Risk of
Atrioventricular Block in Patients Undergoing Transcatheter Aortic Valve Implantation1218Ashraf Hamdan, Victor Guetta, Robert Klempfner, Eli Konen, Ehud Raanani,
Michael Glikson, Orly Goitein, Amit Segev, Israel Barbash, Paul Fefer, Dan Spiegelstein,
Ilan Goldenberg, Ehud SchwammenthalAtrioventricular membranous septum (MS) length, which can be easily measured using contrast-
enhanced computed tomography, represents an anatomic surrogate of the distance between the
aortic annulus and the bundle of His and may therefore be inversely related to the risk of
conduction system abnormalities after transcatheter aortic valve implantation. The study by the
authors demonstrated that a short MS, deep prosthesis implantation relative to a given MS length,
and calciﬁcation in the basal septum may facilitate mechanical compression of the conduction
tissue located in the muscular septum and therefore predict a high-degree of atrioventricular
block and the need for permanent pacemaker implantation after transcatheter aortic valve
implantation with self-expandable valves.PERIPHERAL A Prospective, Multicenter Study of a Novel Mesh-Covered Carotid Stent:
The CGuard CARENET Trial (Carotid Embolic Protection Using MicroNet)1229Joachim Schofer, Piotr Musiałek, Klaudija Bijuklic, Ralf Kolvenbach, Mariusz Trystula,
Zbigniew Siudak, Horst SievertTo evaluate the safety and efﬁcacy of the CGuard Carotid Embolic Protective Stent system,
30 consecutive patients meeting the inclusion criteria were enrolled. Protection devices were used
in all procedures. Procedure success was 100% with no procedural complications. The 30-day
major adverse cardiac or cerebrovascular event rate (death, myocardial infarction, or stroke) was
0%. New ipsilateral ischemic lesions in diffusion-weighted magnetic resonance imaging occurred
in 37.0% of patients (average lesion volume of 0.039  0.08 cm3). At 30-day follow-up only 1
new minor lesion occurred. The use of the CGuard system in patients undergoing carotid artery
stenting is feasible and safe.n EDITORIAL COMMENT
Cerebral Embolization: The Cost of Doing Invasive Business 1235
Robert D. SaﬁanCONTINUED ON PAGE A-22
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AUGUST 17, 2015 VOLUME 8, NUMBER 9The Effect of Post-Exercise Ankle-Brachial Index on Lower Extremity Revascularization 1238
Tarek A. Hammad, Jason A. Streﬂing, Paul R. Zellers, Grant W. Reed,
Sridhar Venkatachalam, Ashley M. Lowry, Heather L. Gornik, John R. Bartholomew,
Eugene H. Blackstone, Mehdi H. ShishehborThe authors examined the effect of post-exercise ankle-brachial index (ABI) on the incidence of lower
extremity (LE) revascularization, major adverse cardiovascular events (MACE), and mortality. A total
of 2,791 patients were classiﬁed into group 1: normal resting (NR)/normal post-exercise (NE); group
2: NR/abnormal post-exercise (AE); group 3: abnormal resting (AR)/NE; and group 4: AR/AE.
Compared with group 1 (NR/NE), group 2 (NR/AE) had increased LE revascularization (propensity-
matched adjusted hazard ratio [HR]: 6.63, 95% conﬁdence interval [CI]: 3.13 to 14.04; p < 0.001).
When resting ABI was abnormal, group 4 (AR/AE) compared with group 3 (AR/NE) had increased
LE revascularization (propensity-matched adjusted HR: 2.32, 95% CI: 1.52 to 3.54; p < 0.001). No
difference in MACE or mortality was observed.
SEE ADDITIONAL CONTENT ONLINEn EDITORIAL COMMENT
The Exercise Ankle-Brachial Index: A Leap Forward in Noninvasive Diagnosis
and Prognosis1245Douglas E. Drachman, Joshua A. BeckmanTRANSLATIONAL Acute Thrombogenicity of a Durable Polymer Everolimus-Eluting Stent Relative to
Contemporary Drug-Eluting Stents With Biodegradable Polymer Coatings Assessed
Ex Vivo in a Swine Shunt Model1248Fumiyuki Otsuka, Qi Cheng, Kazuyuki Yahagi, Eduardo Acampado, Alexander Sheehy,
Saami K. Yazdani, Kenichi Sakakura, Kristina Euller, Laura E.L. Perkins,
Frank D. Kolodgie, Renu Virmani, Michael JonerPrevious studies suggest that early stent thrombogenicity is inﬂuenced by several factors including
stent design and polymer coating technology. It remains unclear whether relevant differences
exist with respect to acute thrombogenicity between current drug-eluting stents (DES) using
permanent polymers and those using biodegradable polymers. We demonstrate that the
permanent ﬂuoropolymer-coated Xience Xpedition everolimus-eluting stent exhibits less platelet
aggregation and inﬂammatory cell attachment as compared with 4 CE-marked DES with
biodegradable polymer coatings in an ex vivo swine shunt model. The ﬁndings of this study
support an acute protective effect of Xience everolimus-eluting stent against thrombus formation
relative to contemporary DES with biodegradable polymers.
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AUGUST 17, 2015 VOLUME 8, NUMBER 9IMAGES IN
INTERVENTIONStroke With Valve Tissue Embolization During Transcatheter Aortic Valve Replacement
Treated With Endovascular Intervention1261Amornpol Anuwatworn, Amol Raizada, Shawn Kelly, Tomasz Stys, Orvar Jonsson,
Adam Stys
Recurrent Neoatherosclerosis After Bioresorbable Vascular Scaffold Treatment
of In-Stent Restenosis1264Teresa Bastante, Fernando Rivero, Amparo Benedicto, Javier Cuesta, Fernando Alfonso
n ONLINE FEATURE Percutaneous Luminal Reconstruction of Giant Saphenous
Vein Graft Aneurysme141Tiffany Patterson, Ian Webb, Simon R. Redwood
n ONLINE FEATURE An Unusual Complication After Bioresorbable Scaffold Implantation:
Visualization of Intramural Hematoma by Optical Coherence Tomographye143Bu-Chun Zhang, Antonios Karanasos, Kees-Jan Royaards, Jurgen Ligthart, Evelyn Regar
n ONLINE FEATURE Percutaneous Closure of Right Ventricular Pseudoaneurysm e147
Mohamad Alkhouli, Bryan Waits, Abhishek Chaturvedi, Frederick S. Ling
n ONLINE FEATURE Local Hemodynamics: An Innocent Bystander or a
Critical Factor Regulating Neoatherosclerotic Evolution?e149Michael Michail, Ryo Torii, Tom Crake, Muhiddin Ozkor, Hector M. Garcia-Garcia,
Erhan Tenekecioglu, Yoshinobu Onuma, Anthony Mathur, Patrick W. Serruys,
Christos V. Bourantas
n ONLINE FEATURE Very Late Thrombosis of a Transcatheter Aortic
Valve-in-Valvee151David Martí, Miguel Rubio, Natalia Escribano, Ramón de Miguel, Ignacio Rada,
César Morís
n ONLINE FEATURE THESE ARTICLES DO NOT APPEAR IN THE PRINTED ISSUE.
THEY ARE AVAILABLE IN THE ONLINE VERSION OF THIS ISSUE.LETTERS TO
THE EDITORvon Willebrand Disease After TAVR: The Missing Link? 1266
Philippe Généreux, Frédéric Poulin, Martin B. Leon
Reply
Tobias Spangenberg, Ulrich Budde, Dimitry Schewel, Christian Frerker,
Thomas Thielsen, Karl-Heinz Kuck, Ulrich Schäfer
Quantitative Evaluation of Residual Atrial Septal Defect Following Transseptal
Catheterization for Intracardiac Interventional Procedures1267Jian-Fang Ren, David J. Callans, Francis E. Marchlinski
Reply
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AUGUST 17, 2015 VOLUME 8, NUMBER 9Iatrogenic Atrial Septal Defect After MitraClip Therapy 1270
Jason H. Rogers, Thomas Smith
Reply
Robert Schueler, Christoph Hammerstingl
True Fractional Flow Reserve of Left Main Coronary Artery Stenosis in the Presence
of Downstream Coronary Stenoses1272Naritatsu Saito
Reply
William F. Fearon, Andy S. Yong, Guy Lenders, Gabor G. Toth, Catherine Dao,
David V. Daniels, Nico H.J. Pijls, Bernard De Bruyne
The Role of Drug-Eluting Balloons in Bifurcations: The Remaining Variable to
Fit the Perfect Equation1273Iñigo Lozano, Juan Rondan, Jose M. Vegas, Eduardo Segovia
Reply
Young-Hak Kim, Seung-Jung Park
Radial Artery in Breast Cancer Survivors: A Possible Choice but Always With Caution 1275
Iñigo Lozano, Alberto Batalla, Juan Rondan, Jose M. VegasEDITOR’S PAGE Do You Fear the First of July? 1277
Spencer B. King IIICORRECTION 1279
